Grifols USA LLC
Los Angeles, CA
- UEI
- D48FNWJCJ5H5
- CAGE
- 1N5P5
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2410 Grifols Wy, Los Angeles, CA 90032, USA
- Website
- grifols.com
- Founded
- 1940
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $377,947 |
| FY2025 | $680,336 |
| FY2024 | $609,295 |
| FY2023 | $830,755 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $377,947 |
Contract vehicles
Expired vehicles (2)
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Grifols Therapeutics LLC | Clayton, NC | 325412 Pharmaceutical Preparation Manufacturing |
| FFF Enterprises, Inc. | Temecula, CA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| CSL Behring L.L.C. | King of Prussia, PA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Grifols USA LLC is a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. Registered in the System for Award Management (SAM) since 2001, the company is a for-profit organization that operates as a manufacturer of goods and holds multiple federal contract vehicles. Grifols focuses primarily on producing specialized pharmaceutical products, with a notable emphasis on PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency.
Through its federal contract awards, Grifols USA LLC has consistently supplied critical pharmaceutical products to various federal agencies, predominantly the Department of Veterans Affairs (VA), Centers for Disease Control and Prevention (CDC), and Department of Justice's Bureau of Prisons. The company's contract awards have been predominantly delivery orders for PROLASTIN-C LIQUID and other specialized medications, with contract values ranging from approximately $10,000 to over $500,000. These contracts are consistently awarded on a firm fixed-price basis and do not utilize set-aside designations, indicating Grifols' status as a large, capable business able to meet federal healthcare procurement needs. The majority of these contracts are issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with performance locations spanning multiple VA Veterans Integrated Service Networks and federal medical facilities across the United States.
Grifols USA LLC holds several significant indefinite delivery vehicles (IDVs) that demonstrate its critical role in federal healthcare supply chains. These include a $1.38 billion Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs, a $107.5 million Blanket Purchase Agreement specifically for PROLASTIN-C, and multiple CDC contracts for vaccine supply. The CDC contracts are particularly noteworthy, including a $13.88 million annual contract for the Vaccines for Children (VFC) program and additional contracts for adult vaccines covering hepatitis, pneumococcal, tetanus, diphtheria, herpes zoster, and other critical immunizations. These IDVs span multiple years, with performance periods typically ranging from one to three years, and allow federal agencies to efficiently procure essential medical supplies through established contract vehicles without repetitive solicitations.
Quick answers
Is Grifols USA LLC registered in SAM.gov?
Yes. Grifols USA LLC's SAM.gov registration is active through July 23, 2027.
Which contract vehicles does Grifols USA LLC hold?
Grifols USA LLC holds a place on 3 federal contract vehicles, including FSS-61-IB.
How much has Grifols USA LLC received in federal contracts?
Federal contracts obligated $680,336 to Grifols USA LLC in fiscal year 2025 and $2,498,333 in fiscal years 2023 through 2027.
How does Grifols USA LLC rank among federal contractors?
Grifols USA LLC ranked #84 in NAICS 325412 in FY2025.
What is Grifols USA LLC's most recent federal award?
Grifols USA LLC's most recent federal contract award is Prolastin-c liquid, human 1000MG/VIL (36C26026F0037), from Veterans Integrated Service Network 20 (VHA), on October 1, 2025.
On GovTribe
See Grifols USA LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors